  Early evaluation of patients who require special care and who have high
death-expectancy in COVID-19, and the effective determination of relevant
biomarkers on large sample-groups are important to reduce mortality. This study
aimed to reveal the routine blood-value predictors of COVID-19 mortality and to
determine the lethal-risk levels of these predictors during the disease
process. The dataset of the study consists of 38 routine blood-values of 2597
patients who died (n = 233) and those who recovered (n = 2364) from COVID-19 in
August-December, 2021. In this study, the histogram-based gradient-boosting
(HGB) model was the most successful machine-learning classifier in detecting
living and deceased COVID-19 patients (with squared F1 metrics F1^2 = 1). The
most efficient binary combinations with procalcitonin were obtained with
D-dimer, ESR, D-Bil and ferritin. The HGB model operated with these feature
pairs correctly detected almost all of the patients who survived and those who
died (precision > 0.98, recall > 0.98, F1^2 > 0.98). Furthermore, in the HGB
model operated with a single feature, the most efficient features were
procalcitonin (F1^2 = 0.96) and ferritin (F1^2 = 0.91). In addition, according
to the two-threshold approach, ferritin values between 376.2 mkg/L and 396.0
mkg/L (F1^2 = 0.91) and pro-calcitonin values between 0.2 mkg/L and 5.2 mkg/L
(F1^2 = 0.95) were found to be fatal risk levels for COVID-19. Considering all
the results, we suggest that many features combined with these features,
especially procalcitonin and ferritin, operated with the HGB model, can be used
to achieve very successful results in the classification of those who live, and
those who die from COVID-19. Moreover, we strongly recommend that clinicians
consider the critical levels we have found for procalcitonin and ferritin
properties, to reduce the lethality of the COVID-19 disease.
